All In Biotech

Free tool

FAERS Monitor: Vevye

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 217469 or its brand name (Vevye, Cyclosporine). Reports on generic versions are filed under their own applications.

Reports

6,159

Serious

85

1% of reports

Hospitalization

20

Death reported

5

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • eye irritation2,454
  • drug ineffective1,688
  • eye pain916
  • ocular hyperaemia538
  • vision blurred479
  • eye pruritus407
  • dry eye296
  • lacrimation increased272
  • ocular discomfort243
  • headache209
  • drug hypersensitivity205
  • eye swelling159
  • condition aggravated145
  • hypersensitivity144
  • foreign body sensation in eyes96

Reports by year received

View as table
YearReports
20221
20232
2024974
20251,814
20263,368

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,000 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
eye irritationSignal2,454152.0147.3353,335
ocular discomfortSignal24375.566.717,419
eye painSignal91656.353.049,062
foreign body sensation in eyesSignal9652.242.74,700
eye pruritusSignal40741.938.116,022
ocular hyperaemiaSignal53839.136.119,778
lacrimation increasedSignal27231.027.67,810
dry eyeSignal29620.418.25,412
eye swellingSignal15914.712.62,004
vision blurredSignal47912.011.04,811
drug ineffectiveSignal1,6884.44.24,685
drug hypersensitivitySignal2053.63.2389
hypersensitivitySignal1442.72.3148
condition aggravated1451.61.435
headache2091.11.03

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.